Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Spironolactone improved symptoms in women with hormonal imbalances and had few side effects.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Lifestyle changes, medications, and fertility treatments can improve PCOS symptoms and prevent complications.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Polycystic ovary syndrome, a disorder causing menstrual issues and infertility, can be treated with lifestyle changes, medication, herbal remedies, surgery, and assisted reproductive techniques like artificial insemination and IVF.

Both oral contraceptives reduced hirsutism in PCOS patients, but adding metformin showed no extra benefit.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

New microneedle method improves hair regrowth treatment delivery.

A young woman developed a vision-threatening eye condition after using minoxidil for hair loss, which improved when she stopped the medication.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Balanced hormones are crucial for women's health, and can be managed with lifestyle changes or hormone therapy if needed.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Hyperandrogenism is a common hormonal disorder in women, often linked to PCOS.